Skip Ribbon Commands
Skip to main content
Menu
Dr Sharon Foo

Dr Foo Anqi Sharon

MBBS (UK), MRCOG (RCOG, UK)

Consultant

KK Women's and Children's Hospital

Specialty: Maternal Fetal Medicine, Obstetrics & Gynaecology

Clinical Appointments

  • Consultant Department of Maternal Fetal Medicine KK Women's and Children's HospitalKK Women's and Children's Hospital

Profile

Dr Sharon Foo is an obstetrician and gynaecologist with a special interest in high-risk obstetrics, obstetric medicine and perinatal medicine. She is interested in research which has an impact on our daily clinical practice and which translate to improved maternal and neonatal outcomes. She is also passionate about global health initiatives to improve maternal and neonatal morbidity and mortality and personally invested in humanitarian medical mission work.

Education

  • SAB & SMC (Spore) OBGYN 2019
  • RCOG (UK) OBGYN 2016
  • MBBS (UK) University College London 2009

Professional Appointments and Committee Memberships

  • Consultant, Maternal Fetal Medicine, KK Women's and Children's Hospital
  • Physician faculty member for SingHealth Obstetrics & Gynaecology Residency Programme
  • Member, Paediatrics/Obstetrics & Gynaecology Taskforce in the Emergency Medicine Academic Clinical Programme, Clinical Services directorate of the SingHealth Duke-NUS Academic Medical Centre

Awards

  • RiSE Residents Committee Award. SingHealth 2014

Research Interests

  • High Risk Obstetrics
  • Neonatal Outcomes

Publications

  • Sharon Foo, Shephali Tagore, Manisha Mathur, Keorany Poun, Maly Sam, Kok Hian Tan, Anette Jacobsen, Kenneth Kwek. A sustainable model to improve maternal health and promote early obstetric care in resource-poor regions. International Journal of Gynaecology & Obstetrics 2019; 145:350-353.
  • Sharon Foo, Yeo Ching Yeo, Shahul Hameed Mohamed Siraj. Laparoscopic management of a rare case of mature cystic teratoma with immature neural tissue and literature review. Journal of Medical Cases Volume 9, Number 12, Dec 2018, pages 390-393.

Research Trials

  • Improving the prediction of spontaneous preterm birth with a novel phosphorylated insulin-like growth factor binding protein-1 quantitative assay 2020.